InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by DiPaolo Mark, 董事. Director active across 3 companies, notably Innoviva, Inc.. Aggregated, 7 disclosures have been published. Activity tracked since 14 May 2021. The latest transaction was disclosed on 19 May 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to DiPaolo Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
12,077 股0Common StockSEC:0001104659-25-051748:0
838 股American Depositary SharesSEC:0000950170-25-056925:0
437 股@ US$9.11100.0% 占其流量American Depositary SharesSEC:0000950170-25-056925:1
13,923 股0Common StockSEC:0001104659-24-073442:0
16,495 股0Common StockSEC:0001104659-23-064210:0
12,647 股0Common StockSEC:0001567619-22-009043:0
17,482 股0Common StockSEC:0001567619-21-010828:0
7 条申报中的 7 条
About DiPaolo Mark
Mark DiPaolo is a Director at Innoviva, Inc. He participates in the governance of the company, bringing his expertise in the biopharmaceutical sector. Mark plays an active role in strategic decision-making for the firm.
